Patent intelligence · US
US 6294574
Compounds and methods for the treatment of inflammatory and immune disorders
Compounds and methods for the treatment of inflammatory and immune disorders
Patent details — US 6294574
- Jurisdiction
- US
- Status
- expired
- Grant date
- Sep 25, 2001
- Expiration
- Sep 20, 2021
- Applicant
- Cytomed, Inc.
- Claims
- 10
- CPC classes
- A61P, A61P29/00, A61P37/00, A61P43/00
Quick answer
US 6294574 (Compounds and methods for the treatment of inflammatory and immune disorders) is held by Cytomed, Inc.. Status: expired. Granted Sep 25, 2001. Expires Sep 20, 2021 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Cytomed, Inc.
- Grant date
- Expiration
- Claims
- 10
- CPC classes
- A61P, A61P29/00, A61P37/00, A61P43/00
More from Cytomed, Inc.
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 6294574?
US 6294574 (Compounds and methods for the treatment of inflammatory and immune disorders) is held by Cytomed, Inc.. Status: expired. Granted Sep 25, 2001. Expires Sep 20, 2021 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 6294574?
Cytomed, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 3 pharmaceutical patents for this assignee.
When does US 6294574 expire?
Our index shows an expiration date of Sep 20, 2021 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.